Super-potent synthetic opioids called nitazenes are spreading across the U.S.
Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDC
Read full article →Tracking Medicare news, policy, and coverage changes.
Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDC
Read full article →“Improving global health should be a top policy priority of the United States,” write Anand Parekh, Tom Daschle, and Bill Frist.
Read full article →What’s next for GLP-1 weight loss drugs? Alex Hogan explores on the new episode of STATus Report. Watch now.
Read full article →Senate Democrats open an inquiry into the Trump administration’s remaking of U.S. vaccine policy, demanding officials produce records by next week.
Read full article →A new infant botulism outbreak puts fancy formulas that position their products as safer than other options under scrutiny.
Read full article →“AI is creating a new and largely overlooked strain on something fundamental to health,” write Sten H. Vermund and Patricia J. Kissinger.
Read full article →Federal law requires most museums and other buildings to be accessible to people with disabilities. But access to what's actually inside is often still limited.
Read full article →KFF’s analysis found that the average number of issuers offering plans on the Marketplaces declined to 9 issuers per state in 2026, compared to 9.6 issuers per state in 2025. The post KFF: Insurer Participation in ACA Marketplaces Is Down appeared first on MedCity News .
Read full article →RFK Jr. presents funding intended to address mental illness and addiction, particularly among homeless people.
Read full article →The speed of DOJ's proposed antitrust settlement with OhioHealth should put other hospitals on notice, experts say.
Read full article →(MedPage Today) -- Cefazolin was effective for the treatment of bacteremia caused by methicillin-susceptible Staphylococcus aureus (MSSA), findings of an international open-label platform trial showed. Among patients hospitalized with penicillin...
Read full article →(MedPage Today) -- The Federal Trade Commission (FTC) and four states sued the World Professional Association for Transgender Health Wednesday, in the latest push by President Donald Trump's administration and others to limit gender-affirming care...
Read full article →